Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Variation in TRAF3IP2 (rs13190932) and Its Association With Psoriasis, Psoriatic Arthritis, and Treatment Outcome With Methotrexate

NCT07086924 is registered in ClinicalTrials.gov with South Valley University as lead sponsor.

NCT NCT07086924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07086924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Variation in TRAF3IP2 (rs13190932) and Its Association With Psoriasis, Psoriatic Arthritis, and Treatment Outcome With Methotrexate
Lead sponsor
South Valley University
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2025
Completion date
June 10, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis, psoriatic arthritis